Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Lung Neoplasms 25Prostatic Neoplasms 23Carcinoma, Non-Small-Cell Lung 15Multiple Myeloma 14Sarcoma 12Leukemia, Myeloid, Acute 12Breast Neoplasms 12Lymphoma, Non-Hodgkin 10Glioma 10Wilms Tumor 9Colorectal Neoplasms 9Carcinoma, Hepatocellular 9Rectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Ovarian Neoplasms 8Osteosarcoma 8Neuroblastoma 8Neoplasm Metastasis 8Myelodysplastic Syndromes 8Rhabdomyosarcoma 7Rhabdoid Tumor 7Pancreatic Neoplasms 7Medulloblastoma 7Hepatoblastoma 7Neuroectodermal Tumors, Primitive, Peripheral 6Mouth Neoplasms 6Melanoma 6Lymphoma 6Histiocytosis, Langerhans-Cell 6Head and Neck Neoplasms 6

Interventions

Adrenalectomy 3Radiosurgery 2Nivolumab 2Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2FAPI-46 2pertuzumab 1olaparib 1lutetium Lu 177 dotatate 1iodophenyl metomidate 1camrelizumab 1apatinib 1X-Rays 1Radiofrequency Ablation 1Observation 1Nephrectomy 1N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride 1Mitotane 1Gefitinib 1Floxuridine 1Erlotinib Hydrochloride 1Dexamethasone 1Cystectomy 1Cryosurgery 1Adosterol 1(18F)GTP1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adrenal Gland Neoplasms × X-Rays × Clear all
NCT00591643 2015-12-28

Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
93 enrolled
Endocrine

Adrenal Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡